clarithromycin has been researched along with chitosan in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (35.71) | 29.6817 |
2010's | 8 (57.14) | 24.3611 |
2020's | 1 (7.14) | 2.80 |
Authors | Studies |
---|---|
Majithiya, RJ; Murthy, RS | 1 |
Gisbert, JP; Olivares, D; Pajares, JM; Torrado, G; Torrado, S | 1 |
García-Ochoa, B; Gómez-Burgaz, M; Torrado-Santiago, S | 1 |
Bhattacharya, S; Ganesh, N; Jain, NK; Ramteke, S | 1 |
Gómez-Burgaz, M; Torrado, G; Torrado, S | 1 |
Harris, R; Heras, A; Lecumberri, E | 1 |
Patel, MM; Vaghani, SS | 1 |
Bonferoni, MC; Caramella, C; Dellera, E; Ferrari, F; Mori, M; Rossi, S; Sandri, G | 1 |
Adebisi, AO; Conway, BR | 1 |
Kawashima, Y; Ogawa, N; Takahashi, C; Yamamoto, H | 1 |
Akachi, Y; Asaka, T; Kawashima, Y; Moriguchi, K; Ogawa, N; Takahashi, C; Tanemura, M; Yamamoto, H | 1 |
Arif, M; Chi, Z; Cong, Y; Dong, Q; Geng, J; Liu, C; Su, J; Wang, H | 1 |
Chen, X; Hu, H; Hu, P; Li, H; Li, P; Shen, Y; Yuan, G; Zou, Y | 1 |
Alshehri, S; Bin-Jumah, M; Gilani, SJ; Imam, SS; Jahangir, MA; Kala, C; Taleuzzaman, M; Yasir, M; Zafar, A | 1 |
14 other study(ies) available for clarithromycin and chitosan
Article | Year |
---|---|
Chitosan-based mucoadhesive microspheres of clarithromycin as a delivery system for antibiotic to stomach.
Topics: Animals; Anti-Bacterial Agents; Chitosan; Clarithromycin; Drug Delivery Systems; Male; Microspheres; Rats; Rats, Wistar; Stomach | 2005 |
Clinical trial evaluating amoxicillin and clarithromycin hydrogels (Chitosan-polyacrylic acid polyionic complex) for H. pylori eradication.
Topics: Acrylic Resins; Adult; Amoxicillin; Anti-Bacterial Agents; Biocompatible Materials; Chitosan; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogels; Male; Middle Aged | 2006 |
Chitosan-carboxymethylcellulose interpolymer complexes for gastric-specific delivery of clarithromycin.
Topics: Anti-Bacterial Agents; Capsules; Carboxymethylcellulose Sodium; Chitosan; Clarithromycin; Diffusion; Drug Carriers; Drug Delivery Systems; Gastric Mucosa; Hydrogen-Ion Concentration; Kinetics; Molecular Weight; Polymers; Solubility; Tablets | 2008 |
Amoxicillin, clarithromycin, and omeprazole based targeted nanoparticles for the treatment of H. pylori.
Topics: Amoxicillin; Animals; Cells, Cultured; Chitosan; Clarithromycin; Drug Carriers; Drug Combinations; Drug Delivery Systems; Drug Stability; Female; Glutamic Acid; Helicobacter Infections; Helicobacter pylori; Male; Mice; Nanoparticles; Omeprazole; Random Allocation | 2009 |
Characterization and superficial transformations on mini-matrices made of interpolymer complexes of chitosan and carboxymethylcellulose during in vitro clarithromycin release.
Topics: Carboxymethylcellulose Sodium; Chitosan; Clarithromycin; Delayed-Action Preparations; Drug Delivery Systems; Polymers; Spectroscopy, Fourier Transform Infrared; X-Ray Diffraction | 2009 |
Chitosan-genipin microspheres for the controlled release of drugs: clarithromycin, tramadol and heparin.
Topics: Analgesics, Opioid; Anti-Bacterial Agents; Anticoagulants; Chemistry, Pharmaceutical; Chitosan; Clarithromycin; Cross-Linking Reagents; Delayed-Action Preparations; Diffusion; Heparin, Low-Molecular-Weight; Iridoid Glycosides; Iridoids; Kinetics; Microscopy, Electron, Scanning; Microspheres; Osmolar Concentration; Particle Size; Surface Properties; Tramadol; X-Ray Diffraction | 2010 |
pH-sensitive hydrogels based on semi-interpenetrating network (semi-IPN) of chitosan and polyvinyl pyrrolidone for clarithromycin release.
Topics: Anti-Bacterial Agents; Calorimetry, Differential Scanning; Chitosan; Clarithromycin; Delayed-Action Preparations; Humans; Hydrogels; Hydrogen-Ion Concentration; Povidone; Spectroscopy, Fourier Transform Infrared; Surface Properties; Wettability; X-Ray Diffraction | 2011 |
Ionic polymeric micelles based on chitosan and fatty acids and intended for wound healing. Comparison of linoleic and oleic acid.
Topics: Anti-Bacterial Agents; Cell Survival; Cells, Cultured; Chitosan; Clarithromycin; Drug Carriers; Drug Compounding; Fibroblasts; Humans; Hydrophobic and Hydrophilic Interactions; Linoleic Acid; Micelles; Nanoparticles; Oleic Acid; Particle Size; Wound Healing | 2014 |
Lectin-conjugated microspheres for eradication of Helicobacter pylori infection and interaction with mucus.
Topics: Adhesiveness; Animals; Anti-Bacterial Agents; Cellulose; Chitosan; Clarithromycin; Concanavalin A; Diffusion; Drug Stability; Gastric Juice; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Membranes, Artificial; Microspheres; Mucins; Mucus; Powder Diffraction; Spectroscopy, Fourier Transform Infrared; Swine; X-Ray Diffraction | 2014 |
Observation of antibacterial effect of biodegradable polymeric nanoparticles on Staphylococcus epidermidis biofilm using FE-SEM with an ionic liquid.
Topics: Anti-Bacterial Agents; Biofilms; Chitosan; Clarithromycin; Drug Carriers; Imidazoles; Ionic Liquids; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Nanoparticles; Polyesters; Polyglycolic Acid; Polymers; Staphylococcus epidermidis | 2015 |
Morphological study of efficacy of clarithromycin-loaded nanocarriers for treatment of biofilm infection disease.
Topics: Anti-Bacterial Agents; Biofilms; Chitosan; Clarithromycin; Colony Count, Microbial; Drug Carriers; Lactic Acid; Micelles; Microbial Viability; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Static Electricity | 2017 |
Ureido-modified carboxymethyl chitosan-graft-stearic acid polymeric nano-micelles as a targeted delivering carrier of clarithromycin for Helicobacter pylori: Preparation and in vitro evaluation.
Topics: Chitosan; Clarithromycin; Drug Carriers; Drug Liberation; Gastric Mucosa; Helicobacter pylori; Micelles; Nanostructures; Particle Size; Stearic Acids | 2019 |
Mucus penetration enhanced lipid polymer nanoparticles improve the eradication rate of Helicobacter pylori biofilm.
Topics: Anti-Bacterial Agents; Biofilms; Biopolymers; Cell Adhesion; Cell Line, Tumor; Chitosan; Clarithromycin; Glycolipids; Helicobacter pylori; Humans; Mucus; Nanoparticles; Polyethylene Glycols | 2019 |
Clarithromycin-Loaded Ocular Chitosan Nanoparticle: Formulation, Optimization, Characterization, Ocular Irritation, and Antimicrobial Activity.
Topics: Adhesiveness; Animals; Anti-Bacterial Agents; Chitosan; Clarithromycin; Delayed-Action Preparations; Drug Carriers; Drug Compounding; Eye; Nanoparticles; Particle Size | 2020 |